Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices

References

• Armony M, Plambeck EL (2005) The impact of duplicate orders on demand estimation and capacity investment. Management Sci. 51(10):1505–1518.Link, Google Scholar
• Azoulay P, Graff Zivin JS, Wang J (2010) Superstar extinction. Quart. J. Econom. 125(2):549–589.Crossref, Google Scholar
• Ball GP, Shah R, Wowak KD (2018) Product competition, managerial discretion, and manufacturing recalls in the US pharmaceutical industry. J. Oper. Management 58–59:59–72.Crossref, Google Scholar
• Bavafa H, Hitt LM, Terwiesch C (2018) The impact of e-visits on visit frequencies and patient health: Evidence from primary care. Management Sci. 64(12):5461–5480.Link, Google Scholar
• Beatty TK, Lade GE, Shimshack J (2021) Hurricanes and gasoline price gouging. J. Assoc. Environ. Resource Econom. 8(2):347–374.Google Scholar
• Beatty TK, Shimshack JP, Volpe RJ (2019) Disaster preparedness and disaster response: Evidence from sales of emergency supplies before and after hurricanes. J. Assoc. Environ. Resource Econom. 6(4):633–668.Google Scholar
• Berndt ER, Conti RM, Murphy SJ (2017) The landscape of US generic prescription drug markets, 2004–2016. NBER Working Paper No. 23640, National Bureau of Economic Research, Cambridge, MA.Google Scholar
• Berndt ER, Conti RM, Murphy SJ (2018) The generic drug user fee amendments: An economic perspective. J. Law Biosci. 5(1):103–141.Crossref, Google Scholar
• Blattberg RC, Neslin SA (1990) Sales Promotion: Concepts, Methods, and Strategies (Prentice Hall, Engelwood Cliffs, NJ).Google Scholar
• Bray RL, Yao Y, Duan Y, Huo J (2019) Ration gaming and the bullwhip effect. Oper. Res. 67(2):453–467.Abstract, Google Scholar
• Brigham and Women’s Hospital/Partners in Health/UCSF Institute for Global Health Sciences (2021) COVID protocols v.2.0. Accessed April 29, 2022, https://www.covidprotocols.org.Google Scholar
• Cabral L, Xu L (2021) Seller reputation and price gouging: Evidence from the COVID-19 pandemic. Econom. Inquiry 59(3):867–879.Crossref, Google Scholar
• Cachon GP, Lariviere MA (1999) Capacity choice and allocation: Strategic behavior and supply chain performance. Management Sci. 45(8):1091–1108.Link, Google Scholar
• Catillon M, Majumder MS, Manzi SF, Mandl KD (2020) News coverage and drug shortages during the COVID-19 pandemic. Working paper, Boston Children’s Hospital, Boston, MA.Google Scholar
• Cavallo A, Cavallo E, Rigobon R (2014) Prices and supply disruptions during natural disasters. Rev. Income Wealth 60:S449–S471.Crossref, Google Scholar
• Centers for Disease Control and Prevention (2022) COVID data tracker. Accessed July 15, 2022, https://covid.cdc.gov/covid-data-tracker/#new-hospital-admissions.Google Scholar
• Chakraborti R, Roberts G (2021) Learning to hoard: The effects of preexisting and surprise price-gouging regulation during the COVID-19 pandemic. J. Consumer Policy 44:507–529.Crossref, Google Scholar
• Choo EK, Rajkumar SV (2020) Medication shortages during the COVID-19 crisis: What we must do. Mayo Clinic Proc. 95(6):1112–1115.Crossref, Google Scholar
• Chua K, Conti RM, Becker NV (2021) Assessment of out-of-pocket spending for COVID-19 hospitalizations in the US in 2020. JAMA Network Open 4(10):e2129894.Crossref, Google Scholar
• Cleary (2020) Remdesivir’s hefty price tag ignores NIH investment in its creation. Accessed July 8, 2021, https://tinyurl.com/yc2abbk7.Google Scholar
• Conrad R, Lutter R (2019) Generic competition and drug prices: New evidence linking greater generic competition and lower generic drug prices. Report, U.S. Food and Drug Administration, Silver Spring, MD.Google Scholar
• Conti RM, Berndt ER (2020) Four facts concerning competition in US generic prescription drug markets. Internat. J. Econom. Bus. 27(1):27–48.Crossref, Google Scholar
• Conti RM, Nguyen KH, Rosenthal MB (2018) Generic prescription drug price increases: Which products will be affected by proposed anti-gouging legislation? J. Pharmacy Policy Practice 11(1):1–10.Google Scholar
• Croson R, Donohue K (2006) Behavioral causes of the bullwhip effect and the observed value of inventory information. Management Sci. 52(3):323–336.Link, Google Scholar
• Croson R, Donohue K, Katok E, Sterman J (2014) Order stability in supply chains: Coordination risk and the role of coordination stock. Production Oper. Management 23(2):176–196.Crossref, Google Scholar
• Czeisler MÉ, Marynak K, Clarke KE, Salah Z, Shakya I, Thierry JM, Ali N, et al. (2020) Delay or avoidance of medical care because of COVID-19-related concerns-United States, June 2020. Morbidity Mortality Weekly Rep. 69(36):1250–1257.Crossref, Google Scholar
• DEA (2017) Drugs of abuse: A DEA resource guide. White paper, Drug Enforcement Administration, US Department of Justice, Washington, DC.Google Scholar
• Department of Justice (2020) Adjustments to aggregate production quotas for certain schedule II controlled substances and assessment of annual needs for the list I chemicals ephedrine and pseudoephedrine for 2020, in response to the Coronavirus disease 2019 public health emergency. Notice. Federal Register 85(70):20302–20305.Google Scholar
• FDA (2019) Drug shortages: Root causes and potential solutions. Report, U.S. Department of Health and Human Services, Washington, DC.Google Scholar
• FDA (2020a) FDA publishes list of essential medicines, medical countermeasures, critical inputs required by executive order. Accessed January 28, 2021, https://tinyurl.com/mr2reus9.Google Scholar
• FDA (2020b) FDA drug shortages. Accessed December 2, 2020, https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm.Google Scholar
• Florness D (2020) Fastenal Company (FAST) CEO Dan Florness on Q3 2020 results: Earnings call transcript. Accessed November 30, 2021, https://tinyurl.com/5f2yxmj9.Google Scholar
• Fox ER, Sweet BV, Jensen V (2014) Drug shortages: A complex medical crisis. Mayo Clinic Proc. 89(3):361–373.Crossref, Google Scholar
• Gibney M, Zipp R (2020) COVID-19 “panic buying” adds to already-strained drug supply at US hospitals. S&P Global (August 25), https://tinyurl.com/p32hscer.Google Scholar
• Gibson R, Singh JP (2018) China Rx: Exposing the Risks of America’s Dependence on China for Medicine (Prometheus Books, Amherst, NY).Google Scholar
• Hausman JA (1996) Valuation of new goods under perfect and imperfect competition. Bresnaha T, Gordon R, eds. The Economics of New Goods (University of Chicago Press, Chicago), 207–248.Google Scholar
• Heinen A, Khadan J, Strobl E (2019) The price impact of extreme weather in developing countries. Econom. J. (London) 129(619):1327–1342.Google Scholar
• Hendel I, Nevo A (2006) Sales and consumer inventory. RAND J. Econom. 37(3):543–561.Crossref, Google Scholar
• Holz J, Jiménez-Durán R, Laguna-Müggenburg E (2023) Estimating the distaste for price gouging with incentivized consumer reports. Amer. Econom. J. Appl. Econom. Forthcoming.Google Scholar
• Jia J, Zhao H (2017) Mitigating the US drug shortages through pareto-improving contracts. Production Oper. Management 26(8):1463–1480.Crossref, Google Scholar
• Kahneman D, Knetsch JL, Thaler R (1986) Fairness as a constraint on profit seeking: Entitlements in the market. Amer. Econom. Rev. 76(4):728–741.Google Scholar
• Lee HL, Padmanabhan V, Whang S (1997a) Information distortion in a supply chain: The bullwhip effect. Management Sci. 43(4):546–558.Link, Google Scholar
• Lee HL, Padmanabhan V, Whang S (1997b) The bullwhip effect in supply chains. Sloan Management Rev. 38(3):93–102.Google Scholar
• Lee J, Lee HS, Shin H, Krishnan V (2021) Alleviating drug shortages: The role of mandated reporting induced operational transparency. Management Sci. 67(4):2326–2339.Link, Google Scholar
• Liu J, Bharadwaj A (2020) Drug abuse and the Internet: Evidence from craigslist. Management Sci. 66(5):2040–2049.Link, Google Scholar
• Lupkin S (2020) How coronavirus is affecting the U.S. pharmaceutical supply. NPR (March 12), https://tinyurl.com/mryj66re.Google Scholar
• Mahajan K, Tomar S (2021) COVID-19 and supply chain disruption: Evidence from food markets in India. Amer. J. Agriculture Econom. 103(1):35–52.Crossref, Google Scholar
• Marsh T (2020) Live updates: Fills and prices for unproven COVID-19 treatments. GoodRx (June 16), https://www.goodrx.com/blog/covid-19-treatments-fill-increases-price-changes/.Google Scholar
• Mattingly TJ, Hogue MD (2020) Pharmacy’s call for authorities to aggressively enforce laws addressing price gouging. J. Management Care Spectrum Pharmacy 26(8):952–955.Crossref, Google Scholar
• McKesson (2021) McKesson’s controlled substance monitoring program. Accessed November 2, 2021, https://tinyurl.com/2ty2sctv.Google Scholar
• Mela CF, Jedidi K, Bowman D (1998) The long-term impact of promotions on consumer stockpiling behavior. J. Marketing Res. 35(2):250–262.Crossref, Google Scholar
• Micalizzi L, Zambrotta NS, Bernstein MH (2020) Stockpiling in the time of COVID-19. British J. Health Psych. 26(2):535–543.Crossref, Google Scholar
• National Academies of Sciences, Engineering, and Medicine (2022) Building Resilience into the Nation’s Medical Product Supply Chains (National Academies Press, Washington, DC).Google Scholar
• National Institutes of Health (2020) Coronavirus disease 2019 (COVID-19) treatment guidelines. Accessed January 30, 2021, https://www.covid19treatmentguidelines.nih.gov.Google Scholar
• Neilson H (2009) Price gouging vs. price reduction in retail gasoline markets during Hurricane Rita. Econom. Lett. 105(1):11–13.Crossref, Google Scholar
• Nevo A (2001) Measuring market power in the ready-to-eat cereal industry. Econometrica 69(2):307–342.Crossref, Google Scholar
• PTI (2020) India restricts drug exports as threat of Coronavirus rises. BloombergQuint (March 3), https://tinyurl.com/c47v7x3e.Google Scholar
• Ranney ML, Griffeth V, Jha AK (2020) Critical supply shortages-the need for ventilators and personal protective equipment during the Covid-19 pandemic. New England J. Medicine 382(18):e41.Crossref, Google Scholar
• Robinson JC (2021) Funding of pharmaceutical innovation during and after the COVID-19 pandemic. JAMA 325(9):825–826.Crossref, Google Scholar
• Romano S, Galante H, Figueira D, Mendes Z, Rodrigues AT (2021) Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies. Res. Social Admin. Pharmacy 17(1):1876–1881.Crossref, Google Scholar
• Rowland C, Slater J (2020) Spikes in demand from coronavirus patients are creating shortages of asthma drugs and sedatives for ventilator patients. The Washington Post (April 12), https://www.washingtonpost.com/business/2020/04/12/drug-ventilator-shortage-coronavirus/.Google Scholar
• Schondelmeyer SW, Seifert J, Margraf DJ, Mueller M, Williamson I, Dickson C (2020) COVID-19: The CIDRAP viewpoint. Part 6: Ensuring a resilient US prescription drug supply. Report, Center for Infectious Disease Research and Policy, Minneapolis, MN.Google Scholar
• Schweitzer ME, Cachon GP (2000) Decision bias in the newsvendor problem with a known demand distribution: Experimental evidence. Management Sci. 46(3):404–420.Link, Google Scholar
• Scott S (2021) Patients to have larger say in drug subsidies in agreement to end shortages caused by pandemic. ABC NEWS (September 6), https://tinyurl.com/4rw62ksw.Google Scholar
• Shuman AG, Fox ER, Unguru Y (2020) COVID-19 and drug shortages: A call to action. J. Manag. Care Spec. Pharm. 26(8):945–947.Crossref, Google Scholar
• Shumsky RA, Smith J, Hoen A, Gilbert M (2021) Allocating COVID-19 vaccines: Save one for the second Dose? Working paper, Tuck School of Business, Hanover.Google Scholar
• Song H, Tucker AL, Murrell KL, Vinson DR (2018) Closing the productivity gap: Improving worker productivity through public relative performance feedback and validation of best practices. Management Sci. 64(6):2628–2649.Link, Google Scholar
• Song H, Tucker AL, Graue R, Moravick S, Yang JJ (2020) Capacity pooling in hospitals: The hidden consequences of off-service placement. Management Sci. 66(9):3825–3842.Google Scholar
• Song H, Bergman A, Chen AT, Ellis D, David G, Friedman AB, Bond AM, et al. (2021) Disruptions in preventive care: Mammograms during the COVID-19 pandemic. Health Services Res. 56(1):95–101.Crossref, Google Scholar
• Sterman JD (1989) Modeling managerial behavior: Misperceptions of feedback in a dynamic decision making experiment. Management Sci. 35(3):321–339.Link, Google Scholar
• Sterman JD, Dogan G (2015) ‘I’m not hoarding, I’m just stocking up before the hoarders get here.’: Behavioral causes of phantom ordering in supply chains. J. Oper. Management 39:6–22.Crossref, Google Scholar
• Su X (2010) Intertemporal pricing and consumer stockpiling. Oper. Res. 58(4-part-2):1133–1147.Link, Google Scholar
• Terza JV, Basu A, Rathouz PJ (2008) Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling. J. Health Econom. 27(3):531–543.Google Scholar
• Thomas K (2020) First drug shortage caused by coronavirus, F.D.A. says. but it won’t disclose what drug or where it’s made. New York Times (February 28), https://tinyurl.com/4cf6tm8w.Google Scholar
• The White House (2021) Building resilient supply chains, revitalizing American manufacturing, and fostering broad-based growth. Report, The White House, Washington, DC.Google Scholar
• Tucker AL (2016) The impact of workaround difficulty on frontline employees’ response to operational failures: A laboratory experiment on medication administration. Management Sci. 62(4):1124–1144.Link, Google Scholar
• U.S. Government Accountability Office (2020) COVID-19: Opportunities to improve federal response and recovery efforts. Report, U.S. Government Accountability Office, Washington, DC.Google Scholar
• Wallace D (2020) UK blocks 82 from parallel export. Generics Bulletin (March 20), https://generics.pharmaintelligence.informa.com/GB149734/UK-Blocks-82-From-Parallel-Export.Google Scholar
• Wang YI, Li J, Anupindi R (2023) Manufacturing and regulatory barriers to generic drug competition: A structural model approach. Management Sci. 69(3):1449–1467.Link, Google Scholar
• Woodcock J, Wosinska M (2013) Economic and technological drivers of generic sterile injectable drug shortages. Clinical Pharmacology Therapy 93(2):170–176.Google Scholar
• Wooldridge JM (2014) Quasi-maximum likelihood estimation and testing for nonlinear models with endogenous explanatory variables. J. Econometrics 182(1):226–234.Google Scholar
• Yurukoglu A, Liebman E, Ridley DB (2017) The role of government reimbursement in drug shortages. Amer. Econom. J. Econom. Policy 9(2):348–382.Crossref, Google Scholar